M.S. LEE PHARMA LIMITED SY NO 25

Company Introduction: M.S. LEE PHARMA LIMITED SY NO 25

M.S. LEE PHARMA LIMITED SY NO 25 is a pharmaceutical manufacturing company based in India.

It is a factory (manufacturer).

Lee Pharma Limited is a prominent Indian pharmaceutical company established in 1997. Headquartered in Hyderabad, India, the company specializes in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. Lee Pharma is known for its strong emphasis on quality, innovation, and compliance with international regulatory standards such as USFDA, EDQM, KFDA, TGA, and ANVISA. The company has a global presence, exporting its products to various countries worldwide. Their facilities, including the one at SY NO 25, are dedicated to large-scale production, ensuring high-quality pharmaceutical ingredients for the global market.

M.S. LEE PHARMA LIMITED SY NO 25, India, manufactures and sells a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates. Their product portfolio includes:

Anti-Ulcerants (Proton Pump Inhibitors)

Pantoprazole Sodium

Rabeprazole Sodium

Esomeprazole Magnesium

Omeprazole

Lansoprazole

Anti-Depressants

Sertraline HCl

Fluoxetine HCl

Paroxetine HCl

Anti-Histamines and Anti-Asthmatics

Montelukast Sodium

Fexofenadine HCl

Levocetirizine Dihydrochloride

Lipid-Lowering Agents

Rosuvastatin Calcium

Atorvastatin Calcium

Anti-Diabetics

Dapagliflozin

Empagliflozin

Anti-Epileptics and Neuropathic Pain Agents

Gabapentin

Pregabalin

Anti-Virals

Favipiravir

Remdesivir

Anti-Cancer Agents

Palbociclib

Anti-Gout Agents

Febuxostat

Other APIs across various therapeutic areas such as anti-hypertensives, anti-fungals, muscle relaxants, anti-inflammatory drugs, and immunosuppressants.